In HCC, Regorafenib is known to induce tumor cell apoptosis in 2D HCC cell culture by activating SHP-1-dependent P-STAT3 suppression thus SHP1 acts as a classical tumor suppressor [63]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.